Related Articles Hiding in Plain Sight an Approach to Treating Patients with Severe COVID 19 Infection mBio 2020 Mar 20 11 2 Authors Fedson DS Opal SM Rordam OM Abstract Patients with COVID 19 infection are at risk of acute respiratory disease syndrome ARDS and death The tissue receptor for COVID 19 is ACE2 and higher levels of ACE2 can protect against ARDS Angiotensin receptor blockers and statins upregulate ACE2 Clinical trials are needed to determine whether this drug combination might be used to treat patients with severe COVID 19 infection PMID 32198163 PubMed in process